Real-world Evidence at the American College of Cardiology Scientific Session 2024 Demonstrates Positive Impact of Viz.ai on Suspected Disease Detection and Patient Triage for Improved Care
DAIC
APRIL 4, 2024
in clinical practice for patients with hypertrophic cardiomyopathy (HCM), a commonly inherited heart disease that often goes undetected. At Viz.ai, we invest in our algorithms to ensure the technology reliably detects suspected conditions, including HCM, and improves patient care and outcomes,” said Molly Madziva Taitt , Ph.D.,
Let's personalize your content